-
MH Guide 6.0: Next-level automation and precision in the clinical interpretation of cancer genomic profiling
Molecular Health has launched the latest version of its tertiary analysis solution for genomic profiling featuring improved variant classification and more targeted clinical trial matching.
-
Molecular Health receives IVDR certification for MH Guide
Molecular Health received certification from the European Union for its MH Guide clinical decision support software under the new In Vitro Diagnostics Regulation (EU) 2017/746 (IVDR).
-
Molecular Health and collaborators prove new analytical approach that leverages real-world data to anticipate molecular causation of adverse drug reactions
Molecular Health, the University of Florida, Takeda Oncology, and thinkQ2 published a triad of articles proving a novel systems approach to elucidate mechanisms of drug toxicities.
-
Molecular Health and Gen Era Diagnostics agree to collaborate in the field of precision oncology in Turkey
Gen Era Diagnostics will provide the MH Guide software platform to twenty clinical laboratories in Turkey to use in the interpretation of tumor data for personalized cancer care.
-
MH Guide 5.0: Software for therapy planning in precision oncology now available with a comprehensive update
The updated MH Guide improves searches for patient-relevant clinical trials and features a conversion tool to integrate data from common next-generation sequencers.
-
Molecular Health and Korean EONE-Diagnomics Genome Center (EDGC) join forces in liquid biopsy-based precision medicine
Molecular Health and EONE-Diagnomics Genome Center establish leadership in the precision medicine market for liquid biopsy, helping healthcare providers identify personalized treatment options for patients.
-
Molecular Health and Essen University Hospital launch collaborative project to improve care for COVID-19 patients
In a three-part collaboration with the German Federal Ministry of Health, Molecular Health uses MH Corona Explorer to reveal the molecular basis of COVID-19 disease course.
-
Konyang University Hospital in South Korea relies on MH Guide for personalized cancer medicine
Konyang University Hospital uses MH Guide to perform comprehensive analyses of genes, clinical information, and drugs to provide world-class precision cancer care.
-
Molecular Health and FALCO biosystems team up to provide genetic analysis services using MH Guide/BRCA and MH Guide/Mendel
FALCO biosystems Ltd. will use the products MH Guide/BRCA and MH Guide/Mendel to evaluate inherited genetic variants of BRCA1/2 and other heritable cancer-associated genes.